Comcast has now come to the attention of Chinese antitrust officials for its $3.8 billion acquisition of the animation studio DreamWorks.
The DreamWorks deal, which closed in August, gives Comcast a planned theme park in Shanghai and greater access to the Chinese movie market through the Kung Fu Panda movie franchise and Oriental DreamWorks, a joint venture with Chinese partners that circumvents foreign film quotas.
Comcast also plans a Universal theme park in Beijing — a project reaffirmed by Steve Burke, chief executive of its NBCUniversal unit, in a presentation at an investor conference on Wednesday. NBCU releases films in China through Universal Pictures.
In a market as huge as China’s, economic experts say, Comcast does not pose an anti-competitive threat. The investigation seems to be economic saber-rattling on the global stage, foreign-policy observers say, and a Chinese poke in the ribs of a politically powerful US company at a time when relations between the United States and China have cooled.
Chinese officials think “American movies and TV shows are like a hidden front to pollute Chinese minds,” said James Lewis, senior vice president at the Center for Strategic and International Studies in Washington.
Full Content: Philly
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas